While GSK3β is activated in many of these neurodegenerative diseases, it may not elicit the same outcome since PS1 mutation caused GSK3β activation [79] but led to increased ER-mitochondria tethering [80]. The gene discussed is GSK3B; the disease is neurodegenerative disease.